scholarly journals Hair glucocorticoids in adults with intellectual disabilities and depressive symptoms pre‐ and post‐bright light therapy: First explorations

2021 ◽  
Author(s):  
Pauline C. M. Hamers ◽  
Mesut Savas ◽  
Elisabeth F. C. Rossum ◽  
Yolanda B. Rijke ◽  
Patrick J. E. Bindels ◽  
...  
Keyword(s):  
Depressive Symptoms ◽  
Intellectual Disabilities ◽  
Bright Light ◽  
Light Therapy ◽  
Bright Light Therapy ◽  
Adults With Intellectual Disabilities

The Effect of Ambient Bright Light Therapy on Depressive Symptoms in Persons with Dementia

2007 ◽  
Vol 55 (11) ◽  
pp. 1817-1824 ◽  
Author(s):  
Susan E. Hickman ◽  
Ann Louise Barrick ◽  
Christianna S. Williams ◽  
Sheryl Zimmerman ◽  
Bettye Rose Connell ◽  
...  
Keyword(s):  
Depressive Symptoms ◽  
Bright Light ◽  
Light Therapy ◽  
Bright Light Therapy

scholarly journals Effects of bright light therapy for depression during pregnancy: a randomised, double-blind controlled trial

BMJ Open ◽  
2020 ◽  
Vol 10 (10) ◽  
pp. e038030
Author(s):  
Babette Bais ◽  
Astrid M Kamperman ◽  
Hilmar H Bijma ◽  
Witte JG Hoogendijk ◽  
Jan L Souman ◽  
...  
Keyword(s):  
Depressive Symptoms ◽  
Pregnant Women ◽  
Rating Scale ◽  
Controlled Trial ◽  
Depression Scale ◽  
Bright Light ◽  
Light Therapy ◽  
Secondary Outcome ◽  
Bright Light Therapy ◽  
Double Blind

ObjectivesApproximately 11%–13% of pregnant women suffer from depression. Bright light therapy (BLT) is a promising treatment, combining direct availability, sufficient efficacy, low costs and high safety for both mother and child. Here, we examined the effects of BLT on depression during pregnancy.DesignRandomised, double-blind controlled trial.SettingPrimary and secondary care in The Netherlands, from November 2016 to March 2019.Participants67 pregnant women (12–32 weeks gestational age) with a DSM-5 diagnosis of depressive disorder (Diagnostic and Statistical Manual of Mental Disorders).InterventionsParticipants were randomly allocated to treatment with either BLT (9000 lux, 5000 K) or dim red light therapy (DRLT, 100 lux, 2700 K), which is considered placebo. For 6 weeks, both groups were treated daily at home for 30 min on awakening. Follow-up took place weekly during the intervention, after 6 weeks of therapy, 3 and 10 weeks after treatment and 2 months postpartum.Primary and secondary outcome measuresDepressive symptoms were measured primarily with the Structured Interview Guide for the Hamilton Depression Scale—Seasonal Affective Disorder. Secondary measures were the Hamilton Rating Scale for Depression and the Edinburgh Postnatal Depression Scale. Changes in rating scale scores of these questionnaires over time were analysed using generalised linear mixed models.ResultsMedian depression scores decreased by 40.6%–53.1% in the BLT group and by 50.9%–66.7% in the DRLT group. We found no statistically significant difference in symptom change scores between BLT and DRLT. Sensitivity and post-hoc analyses did not change our findings.ConclusionsDepressive symptoms of pregnant women with depression improved in both treatment arms. More research is necessary to determine whether these responses represent true treatment effects, non-specific treatment responses, placebo effects or a combination hereof.Trial registration numberNTR5476.

scholarly journals Feasibility of Adjunctive Bright Light Therapy for Depressive Symptoms on an Acute Psychiatric Floor

Cureus ◽  
2021 ◽  
Author(s):  
Alisa Trinh ◽  
Pratik Jain ◽  
Shaikh Sabahath ◽  
Dongliang Wang ◽  
James L Megna ◽  
...  
Keyword(s):  
Depressive Symptoms ◽  
Bright Light ◽  
Light Therapy ◽  
Bright Light Therapy
Sign in / Sign up

Export Citation Format

Share Document